New test could flag which men need aggressive prostate cancer treatment and which don't
The Decipher genomic test could help doctors decide which high-risk prostate cancer patients need abiraterone hormone therapy and which can skip it.
Covered by 1 source ·
Every side
-
Fox News
The Decipher genomic test could help doctors decide which high-risk prostate cancer patients need abiraterone hormone therapy and which can skip it.